Last reviewed · How we verify

Amlodipine-folic acid placebos

Shenzhen Ausa Pharmed Co.,Ltd · FDA-approved active Small molecule Quality 2/100

Amlodipine-folic acid placebos is a Calcium channel blocker with vitamin supplement Small molecule drug developed by Shenzhen Ausa Pharmed Co.,Ltd. It is currently FDA-approved for Hypertension, Angina pectoris. Also known as: Amlodipine-folic acid (dummy).

Amlodipine blocks L-type calcium channels to reduce blood pressure, while folic acid supplementation supports cardiovascular and metabolic health.

Amlodipine blocks L-type calcium channels to reduce blood pressure, while folic acid supplementation supports cardiovascular and metabolic health. Used for Hypertension, Angina pectoris.

At a glance

Generic nameAmlodipine-folic acid placebos
Also known asAmlodipine-folic acid (dummy)
SponsorShenzhen Ausa Pharmed Co.,Ltd
Drug classCalcium channel blocker with vitamin supplement
TargetL-type calcium channel (amlodipine); folate metabolism (folic acid)
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Amlodipine is a dihydropyridine calcium channel blocker that inhibits calcium influx into vascular smooth muscle cells, causing vasodilation and reduced peripheral vascular resistance. Folic acid (vitamin B9) is included as a supplementary component to support homocysteine metabolism and reduce cardiovascular risk. This combination product targets hypertension management with adjunctive nutritional support.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Amlodipine-folic acid placebos

What is Amlodipine-folic acid placebos?

Amlodipine-folic acid placebos is a Calcium channel blocker with vitamin supplement drug developed by Shenzhen Ausa Pharmed Co.,Ltd, indicated for Hypertension, Angina pectoris.

How does Amlodipine-folic acid placebos work?

Amlodipine blocks L-type calcium channels to reduce blood pressure, while folic acid supplementation supports cardiovascular and metabolic health.

What is Amlodipine-folic acid placebos used for?

Amlodipine-folic acid placebos is indicated for Hypertension, Angina pectoris.

Who makes Amlodipine-folic acid placebos?

Amlodipine-folic acid placebos is developed and marketed by Shenzhen Ausa Pharmed Co.,Ltd (see full Shenzhen Ausa Pharmed Co.,Ltd pipeline at /company/shenzhen-ausa-pharmed-co-ltd).

Is Amlodipine-folic acid placebos also known as anything else?

Amlodipine-folic acid placebos is also known as Amlodipine-folic acid (dummy).

What drug class is Amlodipine-folic acid placebos in?

Amlodipine-folic acid placebos belongs to the Calcium channel blocker with vitamin supplement class. See all Calcium channel blocker with vitamin supplement drugs at /class/calcium-channel-blocker-with-vitamin-supplement.

What development phase is Amlodipine-folic acid placebos in?

Amlodipine-folic acid placebos is FDA-approved (marketed).

What are the side effects of Amlodipine-folic acid placebos?

Common side effects of Amlodipine-folic acid placebos include Peripheral edema, Headache, Flushing, Fatigue, Dizziness.

What does Amlodipine-folic acid placebos target?

Amlodipine-folic acid placebos targets L-type calcium channel (amlodipine); folate metabolism (folic acid) and is a Calcium channel blocker with vitamin supplement.

Related